AI Everywhere: Online & Onward | MediVoice
Artificial intelligence (AI) is commonly perceived as a tool meant to ease the routine burdens of an average person’s day, and it ranges from virtual programs like ChatGPT, Otter.ai, DataRobot, and more, to the mini-assistants toggled on nearly every app and browser currently on the market.
In reality, AI extends far beyond the limits of an at-home PC setup. In fact, for countless patients worldwide, it can mean the difference between life and death—and clinical researchers contending with unsolvable medical conundrums may now find answers within their reach.
In this edition of MediVoice:
Generating Insights with Generative AI
A highly interactive, human-like layer of AI known as generative AI—or gen-AI—promises unprecedented possibilities for clinical trial processes and outcomes. However, several important considerations must be met before gen-AI can deliver a truly transformative, patient-centric impact.
Read our article to uncover what exactly gen-AI is, and the challenges and opportunities it faces in our highly complex and competitive industry.
领英推荐
Verifying Diversity: Inclusivity Oversight in Life Sciences
Regulation has come a long way in acknowledging the broad gap between global population demographics and the treatment development processes that are intended to represent them. Our Global Compliance and Strategy Analyst Ashni Parekh documents the FDA’s latest guidelines, and the impact they’ll have on clinical trials across the country.
Broadening Breast Cancer Research
Breast cancer continues to plague millions of women worldwide, but upcoming clinical trial findings may provide hope—and long-awaited relief.
In honor of Breast Cancer Awareness Month, read our article to explore the monumental progress happening across the treatment space at a biochemical level, and what this means for patients whose lives depend on it.
Connecting Communities with Clinical Trials
Industry partnerships matter, but so do community coalitions: they ensure crucial healthcare information is diffused from person to person, enabling entire populations to emerge healthy and prepared.
Looking back on Hispanic Heritage Month, watch Emerson Clinical Research Institute President and CEO Fabian Sandoval, MD show how the life sciences sector is equipping local Hispanic/Latinx communities with valuable medical resources, and reducing barriers to clinical trials.